Search

everythinglearnresearchcommunity

for

Search:↓

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Monthly oral corticosteroid pulses effectively treat widespread alopecia areata in young patients.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Yellow dots are common in severe alopecia areata.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Alopecia areata greatly affects people's life quality, mental health, and work life.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Stress can trigger or worsen alopecia areata.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

CTLA4 gene variants are not linked to alopecia areata in Monterrey's Mexican population.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Triamcinolone acetonide mesotherapy may be effective for treating patchy hair loss in alopecia areata.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

People with severe hair loss (Alopecia Areata) have different scalp bacteria than healthy people, which might help predict the condition's progress.

PRP is a safe and effective treatment for limited alopecia areata.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

People with autism are more likely to develop alopecia areata than those without autism.

Alopecia areata is unpredictable, with limited treatment effectiveness, especially in severe cases.

People with alopecia who are more resilient tend to feel less stressed.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.